This article explains what IGF-1 is, how it might affect our health, and whether supplementing with it is a good idea
Bilateral NGs were collected, embedded in Tissue-Tek O.C.T
"Characterization of glucagon-like peptide-1 receptor-binding determinants"
Avoiding vasoconstrictive substances can help minimise peripheral coldness
Combined Protocol Example The following represents a typical 16-week protocol for someone starting both compounds: Tirzepatide: Weekly injection, following standard escalation from 2.5mg to 10mg over 16 weeks HGH: 2 IU upon waking (fasted) daily for weeks 1-4, increasing to 3 IU daily weeks 5-16 Cycle Length: 16-24 weeks, followed by 4-8 week break from HGH (Tirzepatide can continue) Monitoring: Bloodwork at baseline, week 8, and week 16 minimum This conservative approach allows proper adaptation to both compounds while providing meaningful body composition results
Your initial evaluation will be via a telehealth visit, where your provider will review your medical history and weight loss goals and potentially design a personalized tirzepatide treatment plan